previously several years, the UK has witnessed a revolution in clinical pounds‑reduction solutions — within the introduction of semaglutide (Wegovy®) towards the escalating reputation of tirzepatide (Mounjaro®). Now, A different name is drawing awareness in both clinical and public overall health